Cell Responses to IFN-gamma



Status:Archived
Conditions:Psoriasis
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2010
End Date:March 2012

Use our guide to learn which trials are right for you!

Cellular Responses To Intradermal-Gamma (IFN-gamma) in Normal and Psoriatic Patients


IFN-gamma is a central player in the development of psoriasis lesions, which can be involved
a variety of cellular processes in the skin. Dendritic cells are important cells in driving
inflammation in psoriasis through the induction of T cells that produce IL-17 in psoriasis.
Injecting IFN-g into the skin can increase the numbers of T cells and also inflammatory DCs
that produce cytokines involved in IL-17 production. Thus, the investigators hypothesize
that the dendritic cells present in the skin after IFN-g injection polarize IL-17-producing
T cells.



We found this trial at
1
site
New York, New York 10065
?
mi
from
New York, NY
Click here to add this to my saved trials